nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison
|
Eldefrawy, Ahmed |
|
2013 |
31 |
5 |
p. 576-580 5 p. |
artikel |
2 |
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer
|
Lin, Jianqing |
|
2013 |
31 |
5 |
p. 581-588 8 p. |
artikel |
3 |
A prospective randomized multicenter study of Turkish Society of Urooncology comparing two different mechanical bowel preparation methods for radical cystectomy
|
Aslan, Guven |
|
2013 |
31 |
5 |
p. 664-670 7 p. |
artikel |
4 |
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry
|
Montironi, Rodolfo |
|
2013 |
31 |
5 |
p. 557-565 9 p. |
artikel |
5 |
A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma
|
Domont, Julien |
|
2013 |
31 |
5 |
p. 697-705 9 p. |
artikel |
6 |
Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction
|
Kusuda, Yuji |
|
2013 |
31 |
5 |
p. 615-621 7 p. |
artikel |
7 |
Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis
|
Vinarskaja, Anna |
|
2013 |
31 |
5 |
p. 622-627 6 p. |
artikel |
8 |
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
|
Salami, Simpa S. |
|
2013 |
31 |
5 |
p. 566-571 6 p. |
artikel |
9 |
Commentary on “A phase II study of oportuzumab monatox: An immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin.” Kowalski M, Guindon J, Brazas L, Moore C, Entwistle J, Cizeau J, Jewett MA, MacDonald GC
|
See, William A. |
|
2013 |
31 |
5 |
p. 714- 1 p. |
artikel |
10 |
Commentary on “Carboplatin based induction chemotherapy for nonorgan confined bladder cancer—a reasonable alternative for cisplatin unfit patients?” Mertens LS, Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
|
Kamat, Ashish M. |
|
2013 |
31 |
5 |
p. 716-717 2 p. |
artikel |
11 |
Commentary on “Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma.” Wong YN, Litwin S, Vaughn D, Cohen S, Plimack ER, Lee J, Song W, Dabrow M, Brody M, Tuttle H, Hudes G, University of Pennsylvania, Philadelphia, PA
|
See, William A. |
|
2013 |
31 |
5 |
p. 719- 1 p. |
artikel |
12 |
Commentary on “Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition.” Ros MM, Bueno-de-Mesquita HB, Kampman E, Aben KK, Büchner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tjønneland A, Roswall N, Boutron-Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang-Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quirós JR, Sánchez MJ, Buckland G, Larrañaga N, Ehrnström R, Wallström P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands
|
Kamat, Ashish M. |
|
2013 |
31 |
5 |
p. 714-715 2 p. |
artikel |
13 |
Commentary on “Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.” Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Department of Urology, Central Hospital of Bolzano, Bolzano, Italy
|
See, William A. |
|
2013 |
31 |
5 |
p. 718-719 2 p. |
artikel |
14 |
Commentary on “Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.” Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia
|
Kamat, Ashish M. |
|
2013 |
31 |
5 |
p. 716- 1 p. |
artikel |
15 |
Commentary on “Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.” Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada
|
Kamat, Ashish M. |
|
2013 |
31 |
5 |
p. 717-718 2 p. |
artikel |
16 |
Commentary on “The clinical epidemiology of urachal carcinoma: Results of a large, population based study.” Bruins HM, Visser O, Ploeg M, Hulsbergen-van de Kaa CA, Kiemeney LA, Witjes JA, Department of Urology, Radboud University Medical Centre, Utrecht, The Netherlands
|
See, William A. |
|
2013 |
31 |
5 |
p. 720- 1 p. |
artikel |
17 |
Commentary on “The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.” Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria
|
Kamat, Ashish M. |
|
2013 |
31 |
5 |
p. 715-716 2 p. |
artikel |
18 |
Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness
|
Lose, Felicity |
|
2013 |
31 |
5 |
p. 635-643 9 p. |
artikel |
19 |
Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients
|
Nepple, Kenneth G. |
|
2013 |
31 |
5 |
p. 601-606 6 p. |
artikel |
20 |
Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer
|
Langenhuijsen, Johan F. |
|
2013 |
31 |
5 |
p. 549-556 8 p. |
artikel |
21 |
Dynamic sentinel lymph node biopsy as the new paradigm for the management of penile cancer
|
Yeung, Lawrence L. |
|
2013 |
31 |
5 |
p. 693-696 4 p. |
artikel |
22 |
Editorial Board
|
|
|
2013 |
31 |
5 |
p. iv- 1 p. |
artikel |
23 |
Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry
|
Yang, Bo |
|
2013 |
31 |
5 |
p. 628-634 7 p. |
artikel |
24 |
Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: Implications for novel intraoperative PSMA-based fluorescent imaging techniques
|
Chaux, Alcides |
|
2013 |
31 |
5 |
p. 572-575 4 p. |
artikel |
25 |
Inflammation and prostate cancer
|
Dal Moro, Fabrizio |
|
2013 |
31 |
5 |
p. 712- 1 p. |
artikel |
26 |
Information for Authors
|
|
|
2013 |
31 |
5 |
p. IBC- 1 p. |
artikel |
27 |
Insulin-like growth factor pathway: A link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer?
|
Aggarwal, Rahul R. |
|
2013 |
31 |
5 |
p. 522-530 9 p. |
artikel |
28 |
Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers
|
Namdarian, Benjamin |
|
2013 |
31 |
5 |
p. 649-655 7 p. |
artikel |
29 |
Masthead
|
|
|
2013 |
31 |
5 |
p. IFC- 1 p. |
artikel |
30 |
Molecular markers of kidney injury
|
Lane, Brian R. |
|
2013 |
31 |
5 |
p. 682-685 4 p. |
artikel |
31 |
Non-bladder cancer mortality in patients with urothelial cancer of the bladder
|
Scosyrev, Emil |
|
2013 |
31 |
5 |
p. 656-663 8 p. |
artikel |
32 |
Phase II study of biweekly gemcitabine as first line therapy in CIS of the bladder: What does an aborted trial tell us?
|
Gontero, Paolo |
|
2013 |
31 |
5 |
p. 671-675 5 p. |
artikel |
33 |
Positive margins after radical prostatectomy: Implications for failure and role of adjuvant treatment
|
Swanson, Gregory P. |
|
2013 |
31 |
5 |
p. 531-541 11 p. |
artikel |
34 |
Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery
|
Sciarra, Alessandro |
|
2013 |
31 |
5 |
p. 607-614 8 p. |
artikel |
35 |
Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy
|
Pierorazio, Phillip M. |
|
2013 |
31 |
5 |
p. 589-594 6 p. |
artikel |
36 |
Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: The Cleveland Clinic experience with 3 years follow-up
|
Yang, Bo |
|
2013 |
31 |
5 |
p. 686-692 7 p. |
artikel |
37 |
Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer
|
Oh, Jong Jin |
|
2013 |
31 |
5 |
p. 595-600 6 p. |
artikel |
38 |
Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study
|
Zhu, Yao |
|
2013 |
31 |
5 |
p. 706-711 6 p. |
artikel |
39 |
Serum carcino-embryonic antigen (CEA) and its possible use as tumor marker for secondary tumors in urinary intestinal reservoirs
|
Loeser, Andreas |
|
2013 |
31 |
5 |
p. 644-648 5 p. |
artikel |
40 |
Survey Section Editorial Board
|
|
|
2013 |
31 |
5 |
p. 713- 1 p. |
artikel |
41 |
Table of Contents
|
|
|
2013 |
31 |
5 |
p. v-viii nvt p. |
artikel |
42 |
The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma
|
Woodruff, Daniel Y. |
|
2013 |
31 |
5 |
p. 517-521 5 p. |
artikel |
43 |
Transurethral resection biopsy as part of a saturation biopsy protocol: A cohort study and review of the literature
|
Yates, David R. |
|
2013 |
31 |
5 |
p. 542-548 7 p. |
artikel |
44 |
Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer
|
Ercole, Cesar E. |
|
2013 |
31 |
5 |
p. 505-516 12 p. |
artikel |
45 |
Urothelial carcinoma at the uretero-enteric junction: Multi-center evaluation of oncologic outcomes after radical nephroureterectomy
|
Youssef, Ramy F. |
|
2013 |
31 |
5 |
p. 676-681 6 p. |
artikel |
|